BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
Go back to BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany| Pfizer Inc. (NYSE: PFE) | Delayed: 27.76 -0.03 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.79 | 52 Week High | $37.39 | |||
| Open | $27.76 | 52 Week Low | $28.25 | |||
| Day High | $27.76 | P/E | 16.82 | |||
| Day Low | $27.76 | EPS | $1.65 | |||
| Volume | 384,987 | |||||
